通过重塑瘤微环境,SLC11A1促进脏清细胞癌 (KIRC) 的进展
Ding Wu1, Yulin Zhou1, Xiuquan Shi2
1Department of Urology, Jinling Hospital, Jinling School of Clinical Medicine, Nanjing Medical University, Nanjing 210002, Jiangsu, China.
Toxicology and applied pharmacology
|May 18, 2024
概括
溶性载体家族11成员1 (SLC11A1) 在脏清细胞癌 (KIRC) 中高度表达,并驱动瘤生长和免疫抑制. 准SLC11A1可能为KIRC提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 脏清细胞癌 (KIRC) 是一种具有高死亡率的侵袭性癌症.
- 溶性载体家族11成员1 (SLC11A1) 是一种与单细胞相关的蛋白质,其在KIRC中的作用尚不清楚.
研究的目的:
- 研究KIRC中SLC11A1的表达,生物作用和治疗潜力.
- 分析SLC11A1与KIRC中的瘤生长,免疫反应和特定生物标志物的相关性.
主要方法:
- 使用TIMER和UALCAN数据库进行表达和预后分析.
- 进行了体外测试 (殖民地形成,EDU,transwell) 和体内异种移植模型.
- 通过流式细胞计量评估巨细胞极化和CD8+ T细胞反应.
主要成果:
- 在KIRC组织和细胞系中,SLC11A1的表达很高.
- 降低SLC11A1的调控抑制了KIRC细胞的增殖,迁移,入侵和免疫细胞活动,阻碍了瘤的生长.
- SLC11A1与CCL2和PD-L1正相关,激活了JAK/STAT3通路.
结论:
- 通过CCL2和PD-L1介导的JAK/STAT3通路,SLC11A1促进了KIRC的进展和免疫逃避.
- SLC11A1代表了KIRC治疗的潜在治疗标.
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


